Lixte Biotechnology Holdings Stock Volume Indicators On Balance Volume
| LIXTW Stock | USD 0.03 0 21.30% |
| Symbol |
Indicator |
The output start index for this execution was zero with a total number of output elements of sixty-one. The On Balance Volume indicator was developed by Joe Granville to show time series momentum that relates Lixte Biotechnology volume to price change. It can show when Lixte Biotechnology is accumulated or sold by a large number of investors.
Lixte Biotechnology Technical Analysis Modules
Most technical analysis of Lixte Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lixte from various momentum indicators to cycle indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lixte Biotechnology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lixte Biotechnology Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lixte Biotechnology Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Lixte Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lixte Biotechnology's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Lixte Biotechnology's intrinsic value. In addition to deriving basic predictive indicators for Lixte Biotechnology, we also check how macroeconomic factors affect Lixte Biotechnology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 8.56E-4 | 0.001613 | 0.001059 | Price To Sales Ratio | 11.69 | 10.52 | 9.35 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lixte Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lixte Biotechnology's short interest history, or implied volatility extrapolated from Lixte Biotechnology options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | FinTech Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Social Domain Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Momentum Invested over 60 shares | |
Additional Tools for Lixte Stock Analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.